Table 4.
Baseline levels of fasting glycemia and impaired fasting glucose or type 2 diabetes mellitus prevalence according to treatment experience.
| Naïve Absolute (relative) counts or mean±SEM |
Treatment experienced Absolute (relative) counts or mean±SEM |
P | |
|---|---|---|---|
| All patients | |||
|
| |||
| Glycemia (mmol/L) | 5.71±0.15 | 6.41±0.16 | 0.006 |
|
| |||
| IFG | 19 (17.1) | 74 (28.6) | 0.008 |
|
| |||
| T2DM | 23 (20.7) | 65 (25.1) | 0.411 |
|
| |||
| IFG or T2DM | 42 (37.8) | 139 (53.7) | 0.005 |
|
| |||
| Only F4 fibrosis patients | |||
|
| |||
| Glycemia (mmol/L) | 6.16±0.23 | 6.86±0.26 | 0.637 |
|
| |||
| IFG | 10 (23.3) | 36 (28.3) | 0.535 |
|
| |||
| T2DM | 13 (30.2) | 41 (32.3) | 0.921 |
|
| |||
| IFG or T2DM | 23 (53.5) | 77 (60.6) | 0.411 |